Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Baxter

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Cardiovascular Drugs and Therapy|June 18, 1999
Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanismM M Mocanu, S Gadgil, D M Yellon, et al.
Frontiers in Pediatrics|November 29, 2023
Surfacing undiagnosed disease: consideration, counting and codingMegan F Baxter, Michele Hansen, Dylan Gration, et al.
The British Journal of Dermatology|September 21, 2004
Linear IgA disease in association with chronic lymphocytic leukaemiaN Usmani, K F Baxter, J A Child, et al.
Cardiovascular Research|August 6, 2002
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?Derek J Hausenloy, Helen L Maddock, Gary F Baxter, et al.
Journal of Neurochemistry|August 1, 1986
Effect of altered blood plasma osmolalities on regional brain amino acid concentrations and focal seizure susceptibility in the ratC F Baxter, C G Wasterlain, K L Hallden, et al.
The American Journal of Physiology|October 1, 1989
Erythrocytes fail to induce glutathione in response to diethyl maleate or hyperoxiaD T Phelps, S M Deneke, D F Baxter, et al.
The Journal of Dermatological Treatment|December 9, 2003
Retrospective survey of serum lipids in patients receiving more than three courses of isotretinoinK F Baxter, T C Ling, J H Barth, et al.
Circulation|December 1, 1994
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioningG F Baxter, M S Marber, V C Patel, et al.
Disability and Rehabilitation. Assistive Technology|December 24, 2015
Validating a measure to assess factors that affect assistive technology use by students with disabilities in elementary and secondary educationSusan A Zapf, Marcia J Scherer, Mary F Baxter, et al.
Journal of Neurochemistry|April 1, 1977
Brain gamma-aminobutyric acid, glutamic acid decarboxylase, glutamate, and ammonia in mice during hyperbaric oxygenationM D Faiman, R J Nolan, C F Baxter, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Cardiovascular Drugs and Therapy|June 18, 1999
Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanismM M Mocanu, S Gadgil, D M Yellon, et al.
Frontiers in Pediatrics|November 29, 2023
Surfacing undiagnosed disease: consideration, counting and codingMegan F Baxter, Michele Hansen, Dylan Gration, et al.
The British Journal of Dermatology|September 21, 2004
Linear IgA disease in association with chronic lymphocytic leukaemiaN Usmani, K F Baxter, J A Child, et al.
Cardiovascular Research|August 6, 2002
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?Derek J Hausenloy, Helen L Maddock, Gary F Baxter, et al.
Journal of Neurochemistry|August 1, 1986
Effect of altered blood plasma osmolalities on regional brain amino acid concentrations and focal seizure susceptibility in the ratC F Baxter, C G Wasterlain, K L Hallden, et al.
The American Journal of Physiology|October 1, 1989
Erythrocytes fail to induce glutathione in response to diethyl maleate or hyperoxiaD T Phelps, S M Deneke, D F Baxter, et al.
The Journal of Dermatological Treatment|December 9, 2003
Retrospective survey of serum lipids in patients receiving more than three courses of isotretinoinK F Baxter, T C Ling, J H Barth, et al.
Circulation|December 1, 1994
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioningG F Baxter, M S Marber, V C Patel, et al.
Disability and Rehabilitation. Assistive Technology|December 24, 2015
Validating a measure to assess factors that affect assistive technology use by students with disabilities in elementary and secondary educationSusan A Zapf, Marcia J Scherer, Mary F Baxter, et al.
Journal of Neurochemistry|April 1, 1977
Brain gamma-aminobutyric acid, glutamic acid decarboxylase, glutamate, and ammonia in mice during hyperbaric oxygenationM D Faiman, R J Nolan, C F Baxter, et al.
Pageof 21